These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 19084458)

  • 1. Comments on the original article by Soubrier et al. "Effects of anti-tumor necrosis factor therapy on lipid profile in patients with rheumatoid arthritis".
    Seriolo B; Paoliono S; Ferrone C; Cutolo M
    Joint Bone Spine; 2009 Jan; 76(1):117-8; author reply 118. PubMed ID: 19084458
    [No Abstract]   [Full Text] [Related]  

  • 2. The effects of TNF-alpha blocking therapy on lipid levels in rheumatoid arthritis: a meta-analysis.
    Payet S; Pereira B; Soubrier M; Mathieu S
    Semin Arthritis Rheum; 2012 Feb; 41(4):e4-5; author reply e6. PubMed ID: 22154222
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of etanercept or infliximab treatment on lipid profile and insulin resistance in patients with refractory rheumatoid arthritis.
    Seriolo B; Paolino S; Ferrone C; Cutolo M
    Clin Rheumatol; 2007 Oct; 26(10):1799-800. PubMed ID: 17646897
    [No Abstract]   [Full Text] [Related]  

  • 4. Lipid profile of rheumatoid arthritis patients treated with anti-tumor necrosis factor-alpha drugs changes according to disease activity and predicts clinical response.
    Cacciapaglia F; Anelli MG; Rinaldi A; Serafino L; Covelli M; Scioscia C; Iannone F; Lapadula G
    Drug Dev Res; 2014 Nov; 75 Suppl 1():S77-80. PubMed ID: 25381986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Demonstration of response in rheumatoid arthritis patients who are nonresponders according to the American College of Rheumatology 20% criteria: the paradox of beneficial treatment effects in nonresponders in the ATTRACT trial. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy.
    Boers M;
    Arthritis Rheum; 2001 Nov; 44(11):2703-4. PubMed ID: 11710727
    [No Abstract]   [Full Text] [Related]  

  • 6. Comments on Falgarone et al. editorial entitled "TNFalpha antagonists in rheumatoid arthritis patients seen in everyday practice".
    Legoff P
    Joint Bone Spine; 2008 Oct; 75(5):626; author reply 626. PubMed ID: 18805723
    [No Abstract]   [Full Text] [Related]  

  • 7. [TNF antagonists in therapy of rheumatoid arthritis].
    Oberpichler-Schwenk H
    Med Monatsschr Pharm; 1999 Nov; 22(11):334-9. PubMed ID: 10596266
    [No Abstract]   [Full Text] [Related]  

  • 8. Increase in plasma levels of adiponectin after administration of anti-tumor necrosis factor agents in patients with rheumatoid arthritis.
    Nagashima T; Okubo-Fornbacher H; Aoki Y; Kamata Y; Kimura H; Kamimura T; Nara H; Iwamoto M; Yoshio T; Okazaki H; Minota S
    J Rheumatol; 2008 May; 35(5):936-8. PubMed ID: 18464318
    [No Abstract]   [Full Text] [Related]  

  • 9. Comments about the editorial by Bénédicte Mugnier and Jean Roudier entitled "Factors predicting responsiveness to anti-TNFalpha therapy in patients with rheumatoid arthritis: using biotherapies rationally".
    Lequerré T; Vittecoq O; Le Loët X
    Joint Bone Spine; 2005 Jul; 72(4):346-7; author reply 347-8. PubMed ID: 16038851
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of smoking on response and drug survival in rheumatoid arthritis patients treated with their first anti-TNF drug: comments on the article by Söderlin et al.
    Park SJ; Shin JI
    Scand J Rheumatol; 2012 Oct; 41(5):411-2. PubMed ID: 23043533
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment disparity related to race/ethnicity and education in rheumatoid arthritis patients: comment on the article by Constantinescu et al.
    Lee SJ; Kremer J; Kavanaugh A;
    Arthritis Rheum; 2009 Aug; 61(8):1141-2. PubMed ID: 19644891
    [No Abstract]   [Full Text] [Related]  

  • 12. Tumor necrosis factor inhibitors for rheumatoid arthritis.
    Scott DL; Kingsley GH
    N Engl J Med; 2006 Aug; 355(7):704-12. PubMed ID: 16914706
    [No Abstract]   [Full Text] [Related]  

  • 13. Anti-tumor necrosis factor-alpha agents for rheumatoid arthritis: assessing longterm safety.
    Hyrich KL; Silman AJ
    J Rheumatol; 2006 May; 33(5):831-3. PubMed ID: 16652412
    [No Abstract]   [Full Text] [Related]  

  • 14. Influence of anti-TNF-alpha infliximab therapy on adhesion molecules associated with atherogenesis in patients with rheumatoid arthritis.
    Gonzalez-Gay MA; Garcia-Unzueta MT; De Matias JM; Gonzalez-Juanatey C; Garcia-Porrua C; Sanchez-Andrade A; Martin J; Llorca J
    Clin Exp Rheumatol; 2006; 24(4):373-9. PubMed ID: 16956426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of TNF-alpha blocking therapy on lipid levels in rheumatoid arthritis: a meta-analysis.
    van Sijl AM; Peters MJ; Knol DL; de Vet RH; Sattar N; Dijkmans BA; Smulders YM; Nurmohamed MT
    Semin Arthritis Rheum; 2011 Dec; 41(3):393-400. PubMed ID: 21665247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drugs for rheumatoid arthritis.
    Treat Guidel Med Lett; 2012 May; 10(117):37-44; quiz 2 p following 44. PubMed ID: 22538522
    [No Abstract]   [Full Text] [Related]  

  • 17. Dr. Keystone, et al, reply.
    J Rheumatol; 2013 May; 40(5):732-3. PubMed ID: 23767071
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of rheumatoid arthritis by inhibition of tumor necrosis factor with infliximab or etanercept].
    Verhoeven AC; Boers M
    Ned Tijdschr Geneeskd; 2001 Nov; 145(47):2294-5. PubMed ID: 11760611
    [No Abstract]   [Full Text] [Related]  

  • 19. Modulation of lipoprotein plasma concentrations during long-term anti-TNF therapy in patients with active rheumatoid arthritis.
    Popa C; van den Hoogen FH; Radstake TR; Netea MG; Eijsbouts AE; den Heijer M; van der Meer JW; van Riel PL; Stalenhoef AF; Barrera P
    Ann Rheum Dis; 2007 Nov; 66(11):1503-7. PubMed ID: 17472994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adalimumab for rheumatoid arthritis?
    Ebell M; Kripke C
    Am Fam Physician; 2006 Feb; 73(3):435-6. PubMed ID: 16479667
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.